( OTCQB: BIXT) today announced positive clinical results from its recently completed Phase 2 randomized, double-blind, placebo-controlled, dose-optimization trial evaluating ProLectin-M in subjects ...
Bioxytran has reported positive results from its completed phase 2 trial of ProLectin‑M, showing rapid and sustained viral clearance in subjects with laboratory‑confirmed acute viral infection. The ...
Adds world renowned GNA site to broaden genetic diversity and strengthen path toward 2026 data catalyst - POTOMAC, MARYLAND / ACCESS Newswire / February 9, 2026 /IGC Pharma, Inc. (NYSE American:IGC) ( ...
Adds world renowned GNA site to broaden genetic diversity and strengthen path toward 2026 data catalyst - POTOMAC, MARYLAND / ACCESS Newswire / February 9, 2026 / IGC Pharma, Inc. (NYSE American:IGC) ...
CEO Andrew Obenshain said the company is preparing for a second-half phase 3 readout for lanifibranor in metabolic dysfunction-associated steatohepatitis (MASH), describing the trial as fully enrolled ...
PCWorld demonstrates using Google’s Gemini AI to diagnose Plex Media Server issues through a systematic four-phase checkup ...
Early-phase oncology trials carry substantial scientific and commercial risk in cancer drug development. Getting them right ...
On February 12, the second - phase project of the ±200 kV DC power transmission project from Yangzhou to Zhenjiang in Jiangsu ...
SMM Hydrogen Energy Express] On February 12, the third phase of the Goldwind Xing'an League Green Hydrogen to Green Methanol ...
Company collaborating with third parties using "proprietary artificial intelligence and machine learning technologies to identify nonspecific responses and understand and predict susceptibility to ...
The FDA approved protocol updates to a tasquinimod trial in myelofibrosis, allowing broader enrollment and combination use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results